Ad
related to: tacrolimus class of drug studygoodrx.com has been visited by 100K+ users in the past month
This free app will find the best local deals. - AOL.com
- Over 70,000 Pharmacies
Accepted at Most Major Pharmacies
Search & Compare to Save Now
- See Why People Trust Us
Listen to real Americans explain
how much GoodRx helped them save.
- Transparent Pricing
Healthcare is confusing. We make it
simple. Use GoodRx to start saving.
- Our Social Impact Mission
At GoodRx, values matter. Visit us
to see how we make a difference.
- Over 70,000 Pharmacies
Search results
Results from the WOW.Com Content Network
Tacrolimus, sold under the brand name Prograf among others, is an immunosuppressive drug. After allogenic organ transplant, the risk of organ rejection is moderate. To lower the risk of organ rejection, tacrolimus is given. The drug can also be sold as a topical medication in the treatment of T cell-mediated diseases such as eczema and psoriasis.
mTOR inhibitors are a class of drugs used to treat several human diseases, including cancer, autoimmune diseases, and neurodegeneration. They function by inhibiting the mammalian target of rapamycin (mTOR) (also known as the mechanistic target of rapamycin), which is a serine/threonine-specific protein kinase that belongs to the family of phosphatidylinositol-3 kinase (PI3K) related kinases ...
LCP-Tacro (tacrolimus) is a once-daily dosage version of tacrolimus for prevention of rejection in organ transplant patients in two Phase 3 clinical trials in kidney transplant patients. The first study in stable transplant patients showed that LCP-Tacro was non-inferior in efficacy and safety compared to twice-daily tacrolimus (Prograf ...
Tacrolimus has been found to reduce episodes of organ rejection over a related treatment, the drug ciclosporin, which binds cyclophilin. [ 4 ] [ 5 ] Both the FKBP-tacrolimus complex and the cyclosporin-cyclophilin complex inhibit a phosphatase called calcineurin , thus blocking signal transduction in the T- lymphocyte transduction pathway. [ 6 ]
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response.TNF is involved in autoimmune and immune-mediated disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, psoriasis, hidradenitis suppurativa and refractory asthma, so TNF inhibitors may be used in their ...
Pimecrolimus is an immunosuppressant drug of the calcineurin inhibitor class used in the treatment of atopic dermatitis (eczema). It is available as a topical cream. It was developed and formerly marketed by Novartis under the trade name Elidel .
A tyrosine kinase inhibitor (TKI) is a pharmaceutical drug that inhibits tyrosine kinases. Tyrosine kinases are enzymes responsible for the activation of many proteins by signal transduction cascades. The proteins are activated by adding a phosphate group to the protein (phosphorylation), a step that TKIs inhibit. TKIs are typically used as ...
Tohru Kino (木野 亨, Kino Tōru) is a Japanese chemist and pharmacologist, best known for his discovery of tacrolimus.. While working for Fujisawa Pharmaceutical Company in the 1980s (Astellas Pharma today), Kino and his colleagues found that FK-506 (now called tacrolimus), which is produced by the soil bacterium Streptomyces tsukubaensisis, could be expected to be an immunosuppressive drug.